Carbonyl scavenger and antiatherogenic effects of hydrazine derivatives
- 9 September 2008
- journal article
- research article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 45 (10), 1457-1467
- https://doi.org/10.1016/j.freeradbiomed.2008.08.026
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Deoxycorticosterone Acetate Salt Hypertension in Apolipoprotein E −/− Mice Results in Accelerated AtherosclerosisHypertension, 2008
- Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitorsBritish Journal of Pharmacology, 2008
- Inhibition of the Renin-Angiotensin System Abolishes the Proatherogenic Effect of Uremia in Apolipoprotein E-Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetesPathologie Biologie, 2006
- Hydralazine Inhibits Rapid Acrolein-Induced Protein Oligomerization: Role of Aldehyde Scavenging and Adduct Trapping in Cross-Link Blocking and CytoprotectionMolecular Pharmacology, 2005
- Is there a future for antioxidants in atherogenesis?Molecular Nutrition & Food Research, 2005
- The Oxidative Stress Concept of Nitrate Tolerance and the Antioxidant Properties of HydralazineThe American Journal of Cardiology, 2005
- A comparative study of the expression of monoamine oxidase-A and -B mRNA and protein in non-CNS human tissuesCell and tissue research, 2003
- Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.JCI Insight, 1996
- Antiatherosclerotic Effects of Antihypertensive Drugs: Recent Evidence and Ongoing TrialsClinical and Experimental Hypertension, 1996